Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HCQ-01 trial of hydroxychloroquine in early HIV infection
ISRCTN30019040Phase 2Completed
- Sponsor
- MRC Clinical Trials Unit at UCL
- Start
- May 2008
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in human immunodeficiency virus infection (HIV) comparing Hydroxychloroquine with Placebo (2 arms). Primary endpoint: Change in CD8 T-cell activation. Started May 2008; status: completed.
02
Drugs
hydroxychloroquine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on ISRCTN30019040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN30019040.